- Home
- SCYX vs HOLO Comparison
SCYX vs HOLO Comparison
Compare SCYX & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- HOLO
- Stock Information
- Founded
- SCYX 1999
- HOLO 2018
- Country
- SCYX United States
- HOLO China
- Employees
- SCYX N/A
- HOLO N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- HOLO Computer Software: Programming Data Processing
- Sector
- SCYX Health Care
- HOLO Technology
- Exchange
- SCYX Nasdaq
- HOLO Nasdaq
- Market Cap
- SCYX 50.3M
- HOLO 50.1M
- IPO Year
- SCYX 2014
- HOLO N/A
- Fundamental
- Price
- SCYX $1.18
- HOLO $1.99
- Analyst Decision
- SCYX Buy
- HOLO
- Analyst Count
- SCYX 1
- HOLO 0
- Target Price
- SCYX N/A
- HOLO N/A
- AVG Volume (30 Days)
- SCYX 165.3K
- HOLO 4.2M
- Earning Date
- SCYX 11-06-2024
- HOLO 12-23-2024
- Dividend Yield
- SCYX N/A
- HOLO N/A
- EPS Growth
- SCYX N/A
- HOLO N/A
- EPS
- SCYX N/A
- HOLO N/A
- Revenue
- SCYX $8,566,000.00
- HOLO $32,242,196.00
- Revenue This Year
- SCYX N/A
- HOLO N/A
- Revenue Next Year
- SCYX $145.59
- HOLO N/A
- P/E Ratio
- SCYX N/A
- HOLO N/A
- Revenue Growth
- SCYX N/A
- HOLO 326.95
- 52 Week Low
- SCYX $1.15
- HOLO $2.01
- 52 Week High
- SCYX $3.07
- HOLO $1,968.00
- Technical
- Relative Strength Index (RSI)
- SCYX 28.95
- HOLO 32.61
- Support Level
- SCYX $1.25
- HOLO $2.47
- Resistance Level
- SCYX $1.37
- HOLO $2.88
- Average True Range (ATR)
- SCYX 0.06
- HOLO 0.29
- MACD
- SCYX -0.01
- HOLO 0.03
- Stochastic Oscillator
- SCYX 9.26
- HOLO 2.21
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library.